Market news

Detailed price information for Broadcom Ltd (AVGO-Q) from The Globe and Mail including charting and trades.

PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.

SCHO charges half VanEck's fee while delivering a 1.09 percentage point yield advantage and stronger five-year returns.

VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.

Sprott offers lower fees and higher dividend yield, while VanEck commands $31 billion in assets with broader global exposure to mining companies.

VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position portfolio delivered 47.4% returns over the past year.

PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.

NLR delivered stronger five-year returns and lower costs, but EMLP's infrastructure focus offers steadier performance with half the volatility.

VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.

VanEck's concentrated biotech portfolio surged 30.8% in one year but endured a 39.9% drawdown. iShares offers steadier global healthcare exposure with a 1.5% dividend yield.

State Street's energy ETF delivered 39% returns over one year with a 0.08% expense ratio, while VanEck's nuclear-focused fund posted an 8.1% loss despite a higher dividend yield.

A closer look at the top food ETFs in the U.S. stock market this year, what they are, how they're performing, and what to know before investing in the food sector.

GDX delivered $2,339 on a $1,000 investment versus SLV's $2,196, despite facing lower volatility than its silver counterpart.

Detailed price information for Cameco Corp (CCJ-N) from The Globe and Mail including charting and trades.

Data center ETFs can help investors capture AI growth with higher income and tollbooth style economics.

RSPH offers 60 diversified holdings with lower volatility, while BBH concentrates on 25 biotech leaders with stronger recent returns.

The semiconductor sector had an excellent first half, but investors needed to capture a few different themes in their investing, and this ETF helped them do this.

Compare portfolio concentration, risk profiles, and long-term growth as these two pharma ETFs take different approaches to capturing sector opportunity.